Ivonescimab & NSCLC: PD-L1 Status Impacts Progression-Free Survival
For patients facing advanced squamous non-compact-cell lung cancer (NSCLC), the landscape of treatment options is constantly evolving. Recent findings from the HARMONi-6 trial, published in The … Read more